Thyroid disorders in women

Minerva Medica

Volumn 106, Issue 2, 2015, Pages 109-114

  Li, H ^a   Li, J ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmunity; Estrogens; Neoplasms; Thyroid

Indexed keywords

ESTROGEN; PROLACTIN; SEX HORMONE;

AUTOIMMUNE THYROIDITIS; GOITER; HUMAN; PREVALENCE; REVIEW; SEX CHROMOSOME MOSAICISM; SEX RATIO; THYROID DISEASE; THYROID GLAND TISSUE; THYROID NODULE; THYROID PAPILLARY CARCINOMA; X CHROMOSOME INACTIVATION; FEMALE; MOSAICISM; PHYSIOLOGY; THYROID DISEASES; X CHROMOSOME;

CHROMOSOMES, HUMAN, X; ESTROGENS; FEMALE; HUMANS; MOSAICISM; PROLACTIN; THYROID DISEASES;

EID: 84983467452     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 2008;15:68-75.
2. Singer PA, Cooper DS, Levy EG, Ladenson Pw, Braverman LE, Daniels G et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
3. Effraimidis G, Wiersinga WM. Autoimmune thyroid disease: old and new players. Eur J Endocrinol 2014;170:R241-R52.
4. Fortunato RS, Ferreira ACF, Hecht F, Dupuy C, Carvalho DP. Sexual dimorphism and thyroid dysfunction: A matter of oxidative stress? J Endocrinol 2014;221:R31-R40.
5. Kilfoy BA, Devesa SS, ward MH, Zhang y, Rosenberg PS, Holford TR et al. Gender is an age-speciic effect modiier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;18:1092-100.
6. Gharib H, Papini E, Paschke R.Thyroid nodules: A review of current guidelines, practices, and prospects. Eur J Endocrinol 2008;159:493-505.
7. Brent GA, Davies TF. Hypothyroidism and thyroiditis. In: Polonsky KS, Larsen PR, Kronemberg HM, editors. williams textbook of endocrinology. 12th ed. Philadelphia, PA: w.B. Saunders Company; 2011.p.406-39.
8. Azziz R, woods KS, Reyna R, Key TJ, Knochenhauer ES, yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
9. Gaberš?ek S, Zaletel K, Schwetz V, Pieber T, Obermayer-Pietsch B, Lerchbaum E. Mechanisms in endocrinology: Thyroid and polycystic ovary syndrome. Eur J Endocrinol 2015;172:R9-21.
10. Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. Immune-endocrine interactions in autoimmune thyroid diseases, Neuroimmunomodulation 2008;15:68-75.
11. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996;59:599-614.
12. Shahar S, Boaz M, Hedi O. Prolactin and autoimmunity. Autoimmun Rev 2012;11:465-70.
13. Li J, May w, McMurray Rw. Pituitary hormones and systemic lupus erythematosus. Arthritis Rheum 2005; 52:3701-12.
14. Vanderpump MP, French JM, Appleton D, Tunbridge wM, Kendall-Taylor P. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the whickham Survey cohort. Clin Endocrinol (Oxf) 1998;48:39-44.
15. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary 2005;8:25-30.
16. Sayki Arslan M, Sahin M, Topaloglu O, Tutal E, Karakose M, Gungunes A et al. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol (Oxf) 2013;79:882-6.
17. Ferrari C, Boghen M, Paracchi A, Rampini P, Raiteri F, Benco R et al. Thyroid autoimmunity in hyperprolactinaemic disorder. Acta Endocrinologica 1983;104:35-41.
18. Poyraz BÇ, Aksoy C, Balcolu . Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. European Neuropsychopharmacology 2008;18:667-72.
19. Li J, Shan Z, Teng w. Effects of prolactin on in-vitro interactions between thyrocytes from patients with Graves' disease and autologous peripheral blood mononuclear cells. Chin J Intern Med 2001;40:82-5.
20. Li J, Teng w, Shan Z. Effects of prolactin on HLA-DR and CD40 expressions by human thyrocytes. Chin Med J (Engl) 2001;114:1151-6.
21. Li J, Lan N, Teng w. Study on the expression of prolactin mRNA in thyroid glands of patients with Graves' disease. Chinese Journal of Immunology 2001;12:667-70.
22. Giusti M, Foppiani L, Fazzuoli L, Molinari E, Guido R, Valenti S et al. [An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs]. Recenti Prog Med 1999;90:147-51.
23. Straub RH. The complex role of estrogens in inlammation. Endocr Rev 2007;28:521-74.
24. Li J, McMurray Rw. Effects of cyclic versus sustained estrogen administration on peripheral immune functions in ovariectomized mice. Am J Reprod Immunol 2010;63:274-81.
25. Li J, McMurray Rw. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. Int Immunopharmacol 2006;6: 1413-23.
26. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding speciicity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
27. Li J, McMurray Rw. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZw F1 mouse model. Clin Immunol 2007;123:219-26.
28. Elloso MM, Phie K, Henderson RA, Harris HA, Adelman SJ. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J Endocrinol 2005;185:243-52.
29. Okayasu I, Kong yM, Rose NR. Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clinical Immunol Immunopathol 1981;20:240-5.
30. Guo XQ, Tian EJ, Zhang JL, Zhao SJ, wang JL. The effects of estrogen on experimental autoimmune thyroiditis in rats. Chinese Journal of Endocrinology and Metabolism 2004;20:151-4.
31. Jin Q, Qin J, Jin XJ, Li J, Shan Z, Teng w. Estrogen receptor beta separate activation suppresses Treg subset in spleen of CBA/J mice. Chinese Journal of Immunology 2014;30:433-7.
32. wang SH, Myc A, Koenig RJ, Bretz JD, Arscott PL, Baker JR. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis. Mol Cell Endocrinol 2000;165:163-72.
33. Santin AP, Furlanetto Tw. Role of estrogen in thyroid function and growth regulation. J Thyroid Res 2011;2011:875125-875132.
34. Huang y, Dong w, Li J, Zhang H, Shan Z, Teng w. Differential expression patterns and clinical signiicance of estrogen receptor-Alpha and beta in papillary thyroid carcinoma. BMC Cancer 2014;14:383.
35. Dong w, Li J, Huang y, Zhang H, Shan Z, Teng w. Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter. Med Sci Monit 2012;18:BR351-5.
36. Lima LP, Barros IA, Lisbôa PC, Araújo RL, Silva AC, Rosenthal D et al. Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats. Steroids 2006;71:653-9.
37. Son Hy, Nishikawa A, Okazaki K, Kanki K, yamagishi M, Imazawa T et al. Prolonged effects of beta-estradiol 3-benzoate on thyroid tumorigenesis in gonadectomized rats pretreated with N-bis(2-hydroxypropyl) nitrosamine. Cancer Lett 2003;190:21-9.
38. Furlanetto Tw, Nguyen LQ, Jameson JL. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999;140:5705-11.
39. Vivacqua A, Bonoiglio D, Albanito L, Madeo A, Rago V, Carpino A et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006;70:1414-23.
40. Xu S, Chen G, Peng w, Renko K, Derwahl M. Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules? J Endocrinol 2013;218:125-33.
41. Zeng Q, Chen GG, Vlantis AC, van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Proliferation 2007;40:921-35.
42. Dong w, Zhang H, Li J, Guan H, He L, wang Z et al. Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor alpha and beta. Int J Endocrinol 2013;2013:941568.
43. Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006;14:791-7.
44. Simmonds MJ, Kavvoura FK, Brand OJ, Newby PR, Jackson LE, Hargreaves CE et al. Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: An association study and meta-Analysis. J Clin Endocrinol Metab 2014;99: E127-E31.
45. Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Rstavik KH, Hegedös L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: A possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005;90:5949-53.